Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine effects in mitochondrial schizophrenia
2021-001268-58Phase 4Completed
- Sponsor
- Semmelweis University
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cariprazine in schizophrenia, sponsored by Semmelweis University. Primary endpoint: Change in PANSS total score. Started Mar 2021; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2021-001268-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001268-58.